HOWARD HUGHES CORP/THE (HHC) Stock Fundamental Analysis
NYSE:HHC - New York Stock Exchange, Inc. - US44267D1072 - Common Stock - Currency: USD
Taking everything into account, HHC scores 3 out of 10 in our fundamental rating. HHC was compared to 64 industry peers in the Real Estate Management & Development industry. HHC has a medium profitability rating, but doesn't score so well on its financial health evaluation. While showing a medium growth rate, HHC is valued expensive at the moment.
1. Profitability
1.1 Basic Checks
In the past year HHC was profitable.
In the past year HHC had a positive cash flow from operations.
HHC had positive earnings in 4 of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: HHC reported negative operating cash flow in multiple years.
1.2 Ratios
HHC's Return On Assets of 1.22% is fine compared to the rest of the industry. HHC outperforms 65.57% of its industry peers.
HHC's Return On Equity of 3.40% is fine compared to the rest of the industry. HHC outperforms 73.77% of its industry peers.
Looking at the Return On Invested Capital, with a value of 2.43%, HHC is in the better half of the industry, outperforming 68.85% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.22% | ||
| ROE | 3.4% | ||
| ROIC | 2.43% |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
The Profit Margin of HHC (7.72%) is better than 77.05% of its industry peers.
In the last couple of years the Profit Margin of HHC has declined.
With an excellent Operating Margin value of 18.08%, HHC belongs to the best of the industry, outperforming 85.25% of the companies in the same industry.
In the last couple of years the Operating Margin of HHC has grown nicely.
With a decent Gross Margin value of 41.12%, HHC is doing good in the industry, outperforming 72.13% of the companies in the same industry.
HHC's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 18.08% | ||
| PM (TTM) | 7.72% | ||
| GM | 41.12% |
OM growth 3Y28.95%
OM growth 5Y6.8%
PM growth 3Y26.33%
PM growth 5Y-5.6%
GM growth 3Y4.49%
GM growth 5Y1.42%
2. Health
2.1 Basic Checks
HHC has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, HHC has less shares outstanding
HHC has a worse debt/assets ratio than last year.
2.2 Solvency
HHC has an Altman-Z score of 0.66. This is a bad value and indicates that HHC is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of 0.66, HHC is not doing good in the industry: 60.66% of the companies in the same industry are doing better.
A Debt/Equity ratio of 1.37 is on the high side and indicates that HHC has dependencies on debt financing.
HHC has a worse Debt to Equity ratio (1.37) than 70.49% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.37 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 0.66 |
ROIC/WACC0.35
WACC6.93%
2.3 Liquidity
HHC has a Current Ratio of 1.09. This is a normal value and indicates that HHC is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.09, HHC is doing worse than 65.57% of the companies in the same industry.
A Quick Ratio of 1.08 indicates that HHC should not have too much problems paying its short term obligations.
HHC has a worse Quick ratio (1.08) than 60.66% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.09 | ||
| Quick Ratio | 1.08 |
3. Growth
3.1 Past
HHC shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -8.02%.
HHC shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 13.33% yearly.
Looking at the last year, HHC shows a small growth in Revenue. The Revenue has grown by 1.94% in the last year.
Measured over the past years, HHC shows a small growth in Revenue. The Revenue has been growing by 7.89% on average per year.
EPS 1Y (TTM)-8.02%
EPS 3Y29.57%
EPS 5Y13.33%
EPS Q2Q%-192.86%
Revenue 1Y (TTM)1.94%
Revenue growth 3Y7.34%
Revenue growth 5Y7.89%
Sales Q2Q%-19.3%
3.2 Future
Based on estimates for the next years, HHC will show a decrease in Earnings Per Share. The EPS will decrease by -9.33% on average per year.
Based on estimates for the next years, HHC will show a quite strong growth in Revenue. The Revenue will grow by 9.00% on average per year.
EPS Next Y-134.78%
EPS Next 2Y-8.85%
EPS Next 3Y-9.33%
EPS Next 5YN/A
Revenue Next Year-45.87%
Revenue Next 2Y3.86%
Revenue Next 3Y9%
Revenue Next 5YN/A
3.3 Evolution
The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 32.68, the valuation of HHC can be described as expensive.
70.49% of the companies in the same industry are more expensive than HHC, based on the Price/Earnings ratio.
HHC is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 28.92, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio of 25.48, the valuation of HHC can be described as expensive.
HHC's Price/Forward Earnings ratio is rather cheap when compared to the industry. HHC is cheaper than 80.33% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 21.65, HHC is valued at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 32.68 | ||
| Fwd PE | 25.48 |
4.2 Price Multiples
78.69% of the companies in the same industry are more expensive than HHC, based on the Enterprise Value to EBITDA ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 17.49 |
4.3 Compensation for Growth
The decent profitability rating of HHC may justify a higher PE ratio.
A cheap valuation may be justified as HHC's earnings are expected to decrease with -9.33% in the coming years.
PEG (NY)N/A
PEG (5Y)2.45
EPS Next 2Y-8.85%
EPS Next 3Y-9.33%
5. Dividend
5.1 Amount
No dividends for HHC!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
78.76
+0.12 (+0.15%)
Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)
Earnings (Next)
Inst Owners0.02%
Inst Owner Change0%
Ins Owners4.34%
Ins Owner Change0%
Market Cap3.95B
Analysts82.22
Price Target109.91 (39.55%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-25.66%
Min EPS beat(2)-53.99%
Max EPS beat(2)2.68%
EPS beat(4)2
Avg EPS beat(4)-12.57%
Min EPS beat(4)-53.99%
Max EPS beat(4)9.44%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-0.49%
Min Revenue beat(2)-2.49%
Max Revenue beat(2)1.52%
Revenue beat(4)2
Avg Revenue beat(4)0.34%
Min Revenue beat(4)-5.43%
Max Revenue beat(4)7.75%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-3.51%
PT rev (3m)2.62%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-128.6%
EPS NY rev (1m)-92.44%
EPS NY rev (3m)-92.44%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-10.11%
Revenue NY rev (1m)-9.45%
Revenue NY rev (3m)-9.45%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 32.68 | ||
| Fwd PE | 25.48 | ||
| P/S | 2.56 | ||
| P/FCF | N/A | ||
| P/OCF | 23.2 | ||
| P/B | 1.13 | ||
| P/tB | 1.15 | ||
| EV/EBITDA | 17.49 |
EPS(TTM)2.41
EY3.06%
EPS(NY)3.09
Fwd EY3.92%
FCF(TTM)-4.36
FCFYN/A
OCF(TTM)3.4
OCFY4.31%
SpS30.76
BVpS69.91
TBVpS68.69
PEG (NY)N/A
PEG (5Y)2.45
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.22% | ||
| ROE | 3.4% | ||
| ROCE | N/A | ||
| ROIC | 2.43% | ||
| ROICexc | 2.54% | ||
| ROICexgc | 2.59% | ||
| OM | 18.08% | ||
| PM (TTM) | 7.72% | ||
| GM | 41.12% | ||
| FCFM | N/A |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y34.46%
ROICexcg growth 5Y6.35%
ROICexc growth 3Y34.66%
ROICexc growth 5Y6.93%
OM growth 3Y28.95%
OM growth 5Y6.8%
PM growth 3Y26.33%
PM growth 5Y-5.6%
GM growth 3Y4.49%
GM growth 5Y1.42%
F-Score5
Asset Turnover0.16
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.37 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 10.17 | ||
| Cap/Depr | 187.16% | ||
| Cap/Sales | N/A | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.09 | ||
| Quick Ratio | 1.08 | ||
| Altman-Z | 0.66 |
F-Score5
WACC6.93%
ROIC/WACC0.35
Cap/Depr(3y)191.31%
Cap/Depr(5y)416.72%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-8.02%
EPS 3Y29.57%
EPS 5Y13.33%
EPS Q2Q%-192.86%
EPS Next Y-134.78%
EPS Next 2Y-8.85%
EPS Next 3Y-9.33%
EPS Next 5YN/A
Revenue 1Y (TTM)1.94%
Revenue growth 3Y7.34%
Revenue growth 5Y7.89%
Sales Q2Q%-19.3%
Revenue Next Year-45.87%
Revenue Next 2Y3.86%
Revenue Next 3Y9%
Revenue Next 5YN/A
EBIT growth 1Y-4.33%
EBIT growth 3Y38.42%
EBIT growth 5Y15.23%
EBIT Next Year-11.94%
EBIT Next 3Y10.96%
EBIT Next 5YN/A
FCF growth 1Y45.56%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y413.68%
OCF growth 3Y16.13%
OCF growth 5Y14.45%